Front-page

Second Opinion

Headlines 2002

One on One

Reporter

UN Health

New Frontiers

Industry News

Organized Medicine

 

CME Calendar

February

March

April

May

powered by: FreeFind

Current Issue

December 2002

More Issues

 

 
 
 

Industry News

124 Deaths in Japan Linked to Cancer Drug

At least 124 people have died in Japan since July from side effects believed to be caused by a lung cancer drug sold by British pharmaceutical giant AstraZeneca, according to Japan's health ministry.

More on this Story

Aventis Donates OPV for Africa

With West African countries in the midst of vaccinating millions of children against polio, the world's largest vaccine manufacturer, Aventis Pasteur, has donated 30 million doses of oral polio vaccine to the Global Polio Eradication Initiative.

More on this Story

BMJ: Drug Firms Inventing Diseases

A leading medical journal has blasted drugs companies, accusing them of inventing the "disease" of female impotence to help create a lucrative market for Viagra-style treatments aimed at women.

More on this Story

Janssen Introduces Concerta for ADHD

While there are no definitive data on the incidence of attention deficit hyperactivity disorder in the country-unlike in the United States, where some studies point to an incidence of as high as 14 million-a group of developmental pediatricians, in a survey, said nearly 16 percent (15.75 percent) of their consults in 2001 were of children with ADHD.

More on this Story

MEPI Elects 2003 Officers

The Marketing Executives of the Pharmaceutical-Health Care Industry (MEPI) recently elected its officers for 2003.

More on this Story

MSD Launches Invanz

An important drug for the management of complicated intraabdominal infections was launched by Merck Sharp and Dohme Philippines during the annual convention of the Philippine College of Surgeons December last year.

More on this Story

Schering Expands in Singapore

American pharmaceutical giant Schering-Plough has launched two drug manufacturing plants in Singapore worth US$180 million: a sterile facility for the freeze-drying, finishing, and packaging of leading drugs for the treatment of hepatitis C and Crohn's disease, and another to manufacture Zetia tablets, a new drug for cholesterol management.

More on this Story

UP-PGH and Wyeth Team Up to Save Lives

The University of the Philippines-Philippine General Hospital and Wyeth Philippines have teamed up for a project that gives children a better fighting chance against diseases through adequate health care and supply of medical requirements.

More on this Story

 

 

Updated last April 08, 2003 , Developed and Maintained by JML Internet Solutions
Best viewed with Microsoft Internet Explorer 5 and up at 800x600 resolution

Notice: The articles in this website are meant for information and education purposes only and are not intended to encourage self-diagnosis and self-medication. Readers should consult their physicians for professional medical advice. 

Copyright © 2002, Medical Observer. All rights reserved.